Gold miners just had their best month on record, gaining more than chip stocks managed even at their hottest. A driller in British Columbia’s Golden Triangle confirmed a new mineralized zone extends 600 meters along strike and 580 meters deep, with assays still to come. Bitcoin cleared $80,000 for the first time in three months, then gave some of it back after the Fed’s incoming chair struck a hawkish tone at Jackson Hole.
Mining & Minerals
Juggernaut Exploration Confirms the Whopper Zone Extends 600 Meters Along Strike
Juggernaut Exploration (TSXV: JUGR, OTCPK: JUGRF) reported August 27 that its inaugural drill program at the Big One property in BC’s Golden Triangle has confirmed the Whopper Zone extends 600 meters along strike and 580 meters down-dip, with multiple holes intersecting up to 20.24 meters of quartz-sulphide mineralization containing galena, sphalerite, and chalcopyrite. The zone remains open in every direction tested so far, part of the company’s fully funded 13,000 meter 2026 program across the 22 square kilometer Eldorado zone.
None of these numbers are assay grades. What’s reported so far is a visual and textural description of the core, mineralization that looks similar to surface samples the company previously assayed as high as 263.70 g/t gold equivalent, with the drill assays themselves still pending. The discovery lands in the middle of a historic month for gold miners broadly: the MSCI global gold miners index gained 43% in August, its best monthly gain on record, outpacing even chip stocks at their hottest earlier this year.
Green Energy & Cleantech
Critical Elements Lithium Updates Its Rose West Drill Program in Quebec
Critical Elements Lithium (TSXV: CRE, OTCQX: CRECF) reported assay results and a progress update on August 24 from its Phase 2 2026 exploration program at the Rose West Discovery in Eeyou Istchee, James Bay, Quebec, part of a 10,000 meter systematic drilling campaign underway this summer.
Rose West sits within a lithium pegmatite district the company has been advancing for several years, and this update is incremental infill and expansion drilling rather than a new discovery. Lithium prices remain well off their prior cycle highs, and the project’s economics depend on both continued exploration success and a recovery in lithium demand that has not yet fully materialized.
Biotech & Life Sciences: What Moved the Sector This Week
No small or micro-cap TSX or CSE biotech company had a standout story this week. The FDA calendar was unusually active among larger names instead: Revolution Medicines’ daraxonrasib was approved August 26 as the first targeted therapy for metastatic pancreatic cancer, sold under the brand Rasonque, roughly six and a half months ahead of its original goal date. Bristol Myers Squibb also won accelerated approval for a new multiple myeloma combination therapy the same week, and Moderna and Merck reported that their personalized mRNA melanoma vaccine met its primary and secondary endpoints in a Phase 3 trial covering more than 1,100 patients.
All of that activity concentrated in large-cap names. Small and micro-cap Canadian biotech listings stayed quiet by comparison this week, with no clinical, regulatory, or commercial news that met this publication’s coverage bar.
Tech & Innovation: What Moved the Sector This Week
Nvidia reported earnings August 26, and cybersecurity names had one of their strongest weeks in months: Okta gained more than 28%, CrowdStrike gained 20.5%, and Palo Alto Networks rose almost 13%, all tied to strong results and raised guidance as companies cited booming demand from agentic AI deployments.
Small and micro-cap TSX and CSE tech listings saw mostly routine corporate activity this week, including a CEO appointment, a new board member, and an investor-relations consulting agreement, none of it product or commercial news substantial enough to carry a dedicated writeup. Whether large-cap AI infrastructure spending eventually shows up as orders for smaller suppliers remains an open question.
Crypto & Fintech: What Moved the Sector This Week
Bitcoin cleared $80,000 on August 25 for the first time in more than three months, climbing as high as $81,455 by August 27 on the back of roughly $3 billion in spot Bitcoin ETF inflows for the month, the strongest month for the funds in 2026. The rally partly reversed by the end of the week: Bitcoin pulled back toward $78,000 after Federal Reserve Chair Kevin Warsh struck a hawkish tone in remarks at the Jackson Hole symposium, and spot ETFs saw roughly $202 million in outflows on August 28, ending a nine-session inflow streak.
None of that activity was concentrated in small or micro-cap crypto or fintech equities on the TSX or CSE this week; the price action played out entirely at the token and large-cap ETF level.
What to Watch Next
Assay results from the Whopper Zone drilling are still pending; those grades, not the visual observations reported this week, will determine whether the zone matches the high-grade surface samples the company has previously reported. The 13,000 meter 2026 program is continuing with two rigs.
The company’s 10,000 meter Phase 2 program is continuing through the rest of the summer. Further assay results from the remaining holes are the next data point.
Nothing specific is scheduled that this publication is currently tracking. Readers interested in small-cap biotech catalysts should watch for clinical trial readouts and FDA meeting outcomes in the weeks ahead.
Not yet visible in this week’s news flow. Watch for order announcements or contract wins tied to the ongoing data center buildout.
Key levels to watch are a reclaim of $80,000 to $81,000 for bullish continuation, or a break below $77,000 that could trigger a deeper correction. Small-cap crypto and fintech equities have not shown comparable movement so far.
Sources
- Juggernaut Drills Up To 20.24 Meters Of Quartz-Sulphide Mineralization In Whopper Zone, Resource World Magazine, August 27, 2026
- Gold Miners Are Having a Better Month Than Chips Did in Years, Bloomberg, August 28, 2026
- Critical Elements Lithium Corporation Rose West assay results and program update, Green Stock News, August 24, 2026
- FDA Drug Approval Decisions (daraxonrasib / Rasonque), Life Science Daily News, August 26, 2026
- Stock market news for Aug. 26, 2026 (Okta, CrowdStrike, cybersecurity), CNBC
- Bitcoin (BTC) Daily Market Analysis, August 30, 2026, CoinStats AI
Editorial Disclosure
The Biotech & Life Sciences, Tech & Innovation, and Crypto & Fintech items in this article cover sector-wide activity; no specific company is the subject of coverage in any of the three. Tickers discussed as company subjects in this article: JUGR / JUGRF (Juggernaut Exploration) and CRE / CRECF (Critical Elements Lithium). aktiego.com has received no compensation from any company, IR firm, or third party in connection with this coverage, and no aktiego.com staff member holds a position in any security named above. Press release dates and primary sources were verified against company IR pages, GlobeNewswire, and Resource World Magazine. Both companies named as subjects are under $500 million USD in market capitalization as of the dates referenced above. Juggernaut Exploration’s results reported this week are visual and textural core observations; drill assay grades from the Whopper Zone have not yet been released. Critical Elements Lithium’s Rose West project remains at the exploration and infill drilling stage, with no completed feasibility study on the results discussed above. These are speculative investments carrying significant risk including potential total loss of capital. Digital assets are highly volatile. Coverage on aktiego.com is provided for informational and educational purposes only, aktiego.com is not a registered investment advisor, and nothing in this article constitutes financial, investment, or professional advice. Readers are encouraged to conduct their own due diligence and consult a qualified financial advisor before making any investment decisions. For more information please see our full DISCLAIMER.
